← brief for 2026-08-21 · Slowing decline

Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) Medication Titration Practices in Hemodialysis Patients in the US.

Key takeaways

This study looked at how U.S. dialysis clinics adjust bone-and-mineral medicines: vitamin D types, phosphate binders, and calcimimetics. It followed 23,549 people who started in-center hemodialysis between 2006 and 2015. Doctors adjusted these drugs in very different ways, which shows there are few firm rules to guide them. It describes real-world practice; it does not test which approach works best.

Who did this work

Scialla JJ · Platt A · Wilson J · Hall R · Ephraim PL · Weiner DE · Boulware LE · Pendergast J

Source

Article · PubMed, Nutritional supplements and CKD · 2026 Aug 4
https://pubmed.ncbi.nlm.nih.gov/42620153/